Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VTGN
VTGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VTGN News
Investigation into Vistagen Therapeutics Shareholder Lawsuit
Apr 29 2026
Globenewswire
Vistagen Receives FDA Approval for New Drug Study
Apr 22 2026
Newsfilter
Vistagen Lawsuit Reminder for Investors
Mar 16 2026
PRnewswire
Vistagen Lawsuit Reminder for Investors
Mar 14 2026
Globenewswire
Vistagen Lawsuit Reminder for Investors
Mar 13 2026
Globenewswire
Vistagen Faces Shareholder Class Action Lawsuit
Mar 12 2026
Globenewswire
Investigation Launched into Vistagen Securities Litigation
Mar 12 2026
Globenewswire
Vistagen Faces Class Action Lawsuit; Investors Urged to Act
Mar 11 2026
Globenewswire
Vistagen Lawsuit Reminder for Investors
Mar 10 2026
Globenewswire
Vistagen Faces Class Action Lawsuit Amid 80% Stock Plunge
Mar 10 2026
Globenewswire
Vistagen Therapeutics Shareholder Notice Issued
Mar 10 2026
PRnewswire
Vistagen Lawsuit Reminder for Investors
Mar 07 2026
Globenewswire
Helus Pharma's HLP004 Phase 2 Study Results Disappoint
Mar 05 2026
Benzinga
Vistagen Therapeutics Faces Class Action Lawsuit
Mar 05 2026
Globenewswire
Vistagen Therapeutics Class Action Notice
Mar 05 2026
PRnewswire
Notice of Class Action Lawsuit Against Vistagen Therapeutics
Mar 05 2026
Globenewswire
Show More News
